PL2841110T3 - Sposób dostarczania antygenu - Google Patents

Sposób dostarczania antygenu

Info

Publication number
PL2841110T3
PL2841110T3 PL13726297T PL13726297T PL2841110T3 PL 2841110 T3 PL2841110 T3 PL 2841110T3 PL 13726297 T PL13726297 T PL 13726297T PL 13726297 T PL13726297 T PL 13726297T PL 2841110 T3 PL2841110 T3 PL 2841110T3
Authority
PL
Poland
Prior art keywords
antigen delivery
antigen
delivery
Prior art date
Application number
PL13726297T
Other languages
English (en)
Inventor
Ali Can SAHILLIOGLU
Nesrin OZOREN
Original Assignee
Bogazici Universitesi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bogazici Universitesi filed Critical Bogazici Universitesi
Publication of PL2841110T3 publication Critical patent/PL2841110T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL13726297T 2012-04-24 2013-04-18 Sposób dostarczania antygenu PL2841110T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
TR201204773 2012-04-24
EP13726297.8A EP2841110B1 (en) 2012-04-24 2013-04-18 A method for antigen delivery
PCT/IB2013/053079 WO2013160807A1 (en) 2012-04-24 2013-04-18 A method for antigen delivery

Publications (1)

Publication Number Publication Date
PL2841110T3 true PL2841110T3 (pl) 2019-08-30

Family

ID=48539332

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13726297T PL2841110T3 (pl) 2012-04-24 2013-04-18 Sposób dostarczania antygenu

Country Status (9)

Country Link
US (1) US9725491B2 (pl)
EP (1) EP2841110B1 (pl)
JP (1) JP6026645B2 (pl)
CN (1) CN104684586B (pl)
ES (1) ES2725328T3 (pl)
HU (1) HUE043215T2 (pl)
PL (1) PL2841110T3 (pl)
PT (1) PT2841110T (pl)
WO (1) WO2013160807A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220100664A (ko) * 2019-11-14 2022-07-15 보가지치 유니버시테시 암 면역요법에서의 asc speck

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756196B2 (en) 1999-06-28 2004-06-29 Millennium Pharmaceuticals, Inc. Molecules of the card-related protein family and uses thereof
US6911306B1 (en) 1999-10-18 2005-06-28 Emory University TMS1 compositions and methods of use
JP2007522118A (ja) * 2004-01-30 2007-08-09 ペプリン バイオリピッズ ピーティーワイ エルティーディー 治療用分子および担体分子
ATE426168T1 (de) * 2004-12-23 2009-04-15 Hoffmann La Roche Verwendung von asc als marker fur kolorektalkarzinome
CA2585788C (en) * 2004-12-23 2013-03-05 F. Hoffmann-La Roche Ag Use of cyfra 21-1 as a marker for colorectal cancer
WO2009014863A2 (en) 2007-06-29 2009-01-29 Thomas Jefferson University Asc and pyrin-asc pyroptosomes and uses thereof
US8685400B2 (en) 2007-07-30 2014-04-01 University Of Miami Modulating inflammasome activity and inflammation in the central nervous system
US8334101B2 (en) * 2008-09-26 2012-12-18 University Of Massachusetts Intracellular DNA receptor

Also Published As

Publication number Publication date
WO2013160807A1 (en) 2013-10-31
HUE043215T2 (hu) 2019-08-28
CN104684586A (zh) 2015-06-03
PT2841110T (pt) 2019-05-06
EP2841110B1 (en) 2019-01-09
CN104684586B (zh) 2019-02-05
JP6026645B2 (ja) 2016-11-16
US9725491B2 (en) 2017-08-08
US20150141627A1 (en) 2015-05-21
JP2015515489A (ja) 2015-05-28
EP2841110A1 (en) 2015-03-04
ES2725328T3 (es) 2019-09-23

Similar Documents

Publication Publication Date Title
GB2496016B (en) Methods for obtaining a sequence
SG10201508662SA (en) Methods for drug delivery
SG11201402161YA (en) Conveying device for leads
GB201113087D0 (en) Method
PH12013502174A1 (en) Vaccine delivery method
GB2508701B (en) A knee-walker
PT2820623T (pt) Procedimento para identificação de uma pessoa
GB201116530D0 (en) Method
PL2623440T3 (pl) Sposób eksploatacji instalacji przenośnikowej
GB201117477D0 (en) Method
GB201105436D0 (en) Method
GB201112447D0 (en) Method
PL2925934T3 (pl) Sposób wytwarzania pala
GB201114325D0 (en) Method
GB201101219D0 (en) Method
SG11201503928PA (en) Method for forming a package
GB201117358D0 (en) Method
GB201115783D0 (en) Method
GB2490312B (en) Creating a database entry
HUE043215T2 (hu) Eljárás antigén bejuttatására
GB2501846B (en) Case for a device
SG11201503331UA (en) Method for cold-cutting a lamp
GB201114391D0 (en) Method
GB201106283D0 (en) Method
GB2504558B (en) A delivery aid